Regeneron Study Site

Columbus, Ohio

We've found

1 trials

at this facility

Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Patients With Platinum-Resistant Ovarian Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Columbus, OH

Use our guide to learn which trials are right for you!